Deals
Clorox Drops After Carl Icahn Withdraws Slate of Directors
This article is for subscribers only.
Clorox Co. declined the most in more than a month after investor Carl Icahn withdrew a slate of directors for the company and said shareholders wouldn’t support his plan for a sale.
Clorox, based in Oakland, California, fell $2.96, or 4.3 percent, to $66.44 at 4 p.m. in New York Stock Exchange composite trading, the most since Aug 8. The shares have gained 5 percent this year.